Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases

Claudio Galperin, Ross L. Coppel, M. Eric Gershwin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The use of recombinant proteins has been an invaluable tool for the study of the structure and function of cell components, and the analysis of autoimmune-mediated responses. Furthermore, it has also been instrumental in facilitating the development of reliable assays for the detection of a number of autoantibodies. This article discusses basic aspects of recombinant DNA technology, as well as its applications and limitations in the diagnosis of autoimmune connective tissue diseases such as systemic lupus erythematosus, Sjogren's syndrome, systemic scleroderma, mixed connective tissue disease, autoimmune inflammatory myopathies and primary vasculitides.

Original languageEnglish (US)
Pages (from-to)337-347
Number of pages11
JournalInternational Archives of Allergy and Immunology
Volume111
Issue number4
StatePublished - Dec 1996

Fingerprint

Mixed Connective Tissue Disease
Myositis
Connective Tissue Diseases
Recombinant DNA
Systemic Scleroderma
Sjogren's Syndrome
Cellular Structures
Vasculitis
Autoimmunity
Recombinant Proteins
Systemic Lupus Erythematosus
Autoantibodies
Technology

Keywords

  • Autoantibodies
  • Autoimmunity
  • Connective tissue disease
  • Recombinant antigens

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases. / Galperin, Claudio; Coppel, Ross L.; Gershwin, M. Eric.

In: International Archives of Allergy and Immunology, Vol. 111, No. 4, 12.1996, p. 337-347.

Research output: Contribution to journalArticle

@article{db06b43c1f894a4588150da824194f16,
title = "Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases",
abstract = "The use of recombinant proteins has been an invaluable tool for the study of the structure and function of cell components, and the analysis of autoimmune-mediated responses. Furthermore, it has also been instrumental in facilitating the development of reliable assays for the detection of a number of autoantibodies. This article discusses basic aspects of recombinant DNA technology, as well as its applications and limitations in the diagnosis of autoimmune connective tissue diseases such as systemic lupus erythematosus, Sjogren's syndrome, systemic scleroderma, mixed connective tissue disease, autoimmune inflammatory myopathies and primary vasculitides.",
keywords = "Autoantibodies, Autoimmunity, Connective tissue disease, Recombinant antigens",
author = "Claudio Galperin and Coppel, {Ross L.} and Gershwin, {M. Eric}",
year = "1996",
month = "12",
language = "English (US)",
volume = "111",
pages = "337--347",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases

AU - Galperin, Claudio

AU - Coppel, Ross L.

AU - Gershwin, M. Eric

PY - 1996/12

Y1 - 1996/12

N2 - The use of recombinant proteins has been an invaluable tool for the study of the structure and function of cell components, and the analysis of autoimmune-mediated responses. Furthermore, it has also been instrumental in facilitating the development of reliable assays for the detection of a number of autoantibodies. This article discusses basic aspects of recombinant DNA technology, as well as its applications and limitations in the diagnosis of autoimmune connective tissue diseases such as systemic lupus erythematosus, Sjogren's syndrome, systemic scleroderma, mixed connective tissue disease, autoimmune inflammatory myopathies and primary vasculitides.

AB - The use of recombinant proteins has been an invaluable tool for the study of the structure and function of cell components, and the analysis of autoimmune-mediated responses. Furthermore, it has also been instrumental in facilitating the development of reliable assays for the detection of a number of autoantibodies. This article discusses basic aspects of recombinant DNA technology, as well as its applications and limitations in the diagnosis of autoimmune connective tissue diseases such as systemic lupus erythematosus, Sjogren's syndrome, systemic scleroderma, mixed connective tissue disease, autoimmune inflammatory myopathies and primary vasculitides.

KW - Autoantibodies

KW - Autoimmunity

KW - Connective tissue disease

KW - Recombinant antigens

UR - http://www.scopus.com/inward/record.url?scp=0029822085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029822085&partnerID=8YFLogxK

M3 - Article

C2 - 8957106

AN - SCOPUS:0029822085

VL - 111

SP - 337

EP - 347

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - 4

ER -